LinXis develops targeted therapeutics for the treatment of fibrosis. The basis of these therapeutics are Fibrobodies™, proprietary biological compounds that shuttle potent small molecules to the cells that cause the disease. Our employees are embedded in top-notch laboratories in the Amsterdam UMC (the newly opened Amsterdam UMC Imaging Center) and Utrecht University (Department of Cell Biology). To support our preclinical program, we are currently looking for a Scientist Molecular Immunology.